Phase 2 randomised trial, repurposing danazol and VBaP in low-risk myelodysplastic syndrome: REPAIR MDS
Raghavan, M Jenkins, S Wintrich, S Drayson, M Bunce, C Culligan, D Kulasekararaj, A Wiseman, Dan Foster, B Dunn, J
Raghavan, M
Jenkins, S
Wintrich, S
Drayson, M
Bunce, C
Culligan, D
Kulasekararaj, A
Wiseman, Dan
Foster, B
Dunn, J
Citations
Altmetric:
Abstract
Description
Date
2023
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Raghavan M, Jenkins S, Wintrich S, Drayson M, Bunce C, Culligan D, et al. Phase 2 randomised trial, repurposing Danazol and VBaP in low-risk myelodysplastic syndrome: REPAIR MDS. British journal of haematology. 2023 APR;201:153-. PubMed PMID: WOS:001049283000262. English.